|
|
Protein O-linked N-acetylglucosamine (O-GlcNAc): Nutrient
Sensor and Modulator of Cardiovascular Function
Sunday, April 29 — 8:00-10:00 AM
Washington, DC Convention Center — Room 146B
|
| Chaired: |
Amy J. Davidoff, Univ. of New England
Anne-Marie Seymour, Univ. of Hull |
The goal of this symposium is to explore the
influence of protein O-linked N-acetylglucosamine (O-GlcNAc)
on the function of the cardiovascular system.
The O-linked attachment of GlcNAc onto serine/threonine
residues of both cytosolic and nuclear proteins was first identified by Hart
and colleagues in 1984, and it is becoming increasingly evident that changes
in the level of O-GlcNAc on nucleocytoplasmic proteins play important
roles in mediating signal transduction pathways in part by influencing
protein phosphorylation. Numerous proteins, including transcription
factors, kinases, phosphatases, cytoskeletal proteins, nuclear hormone
receptors, nuclear pore proteins, signal transduction molecules and actin
regulatory proteins have been shown to be modified by O-GlcNAcylation.
Changes in O-GlcNAc levels have also been shown to affect cell
survival, calcium homeostasis, and gene transcription and have been
associated with diseases such as Alzheimer’s, cancer, insulin resistance,
diabetes and atherosclerosis. It is only within the last few years that the
importance of O-GlcNAc in regulating the cardiovascular system has
started to be recognized, initially in the context of diabetic complications
and more recently in the context of ischemic protection.
Therefore, in light of the increasing understanding of
the impact of O-GlcNAc on cellular physiology in general and an
emerging appreciation of its significance in the cardiovascular system, we
believe that a symposium focusing on this topic will be especially timely.
This symposium will attract researchers with interests
in diabetic complications, insulin resistance, ischemic protection, cardiac
and skeletal muscle function, and cellular and molecular physiology and will
therefore be of interest to members of several EB participating societies
and APS sections as listed below.
|
8:00 AM |
The role
of O-GlcNAc in regulating cellular function in response to nutrition
and stress.
Natasha Zachara,
The
Johns Hopkins University School of Medicine
|
|
8:24 AM |
Diabetic
cardiomyopathy, hyperglycemia and enzymatic glycosylation.
Wolfgang H. Dillmann, UCSD
|
|
8:48 AM |
O-GlcNAc,
insulin resistance and the complications of diabetes.
Maria G. Buse, Med. Univ. of South Carolina
|
|
9:12 AM |
O-GlcNAc
and protection of ischemic myocardium.
Steven P. Jones, Univ. of Louisville
|
|
9:36 AM |
O-GlcNAc
and the treatment of hemorrhagic shock.
John C. Chatham, Univ. of Alabama at Birmingham
|
|
|